Early and late activated T-cells
1 paper studies it1 finding
- Human trial1
Interventions
1Allogeneic mesenchymal stem cells
downin humans1
1 study
Allogeneic mesenchymal stem cells
downin humans1
Allogeneic mesenchymal stem cells decrease early and late activated T-cells in humans.
“Early and late activated T-cells were also reduced by MSC therapy.”
Human trialaging frailty6 months postinfusion
The journals of gerontology. Series A, Biological sciences and medical sciences
Latest
The Journals of Gerontology, Series A
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Randomized trial in 30 peopleInterventions